The slip
PARKINSON RECEIPTno. 13195
28 Oct 2026, 16:32 UTCdopamine neurons, braak
predictionSLC16A3 in dopamine neurons tracks Braak Lewy-body stage
registered94372031e4a7d1b2
discovery-0.51 p=0.165 n=9
replication-0.41 p=0.272 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.51, p 0.165)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTc3efa30349edf552037e84cc…
follows 3837916a3328…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13195: SLC16A3 in dopamine neurons, braak
- power
- full sample -0.39 (p 0.109, n 18), 95% CI -0.73 to +0.09. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.42 (p 0.086, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.54 (p 0.021, n 18). not the mix.
- skeptic
- leave-one-out range -0.57 to -0.31, sign flips 0; without severely affected donors -0.39 (p 0.109, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC16A3 in dopamine neurons.
case closed: nothing better to follow up.